Table 1 General overview of the data used for this study.
Feature | Mean | (SD) | N | (%) | Completeness | Feature selection | |
|---|---|---|---|---|---|---|---|
[%] | Algorithm | Clinical | |||||
age | |||||||
Age at diagnosis (years) | 60.25 | (13.96) | 100 | ✓(1) | ✓ | ||
ratly* | |||||||
Ratio between positive and removed lymph nodes | 0.11 | (0.22) | 100 | ✓(2) | |||
rly | |||||||
No. of removed lymph nodes | 8.13 | (7.84) | 98.7 | ✓(3) | |||
ptmm | |||||||
Tumor size [mm] | 20.32 | (13.79) | 87.1 | ✓(4) | ✓ | ||
pts | |||||||
Pathological tumor stage | 100 | ✓(5) | |||||
I | 15,412 | (42.04) | |||||
IIA | 10,848 | (29.59) | |||||
IIB | 4766 | (13.00) | |||||
IIIA | 3145 | (8.57) | |||||
IIIB | 782 | (2.13) | |||||
IIIC | 1705 | (4.65) | |||||
grd | |||||||
Tumor grade | 89.8 | ✓(6) | ✓ | ||||
1 (well differentiated) | 7563 | (20.63) | |||||
2 (moderately differentiated) | 17,926 | (48.89) | |||||
3 (poorly differentiated) | 11,169 | (30.46) | |||||
mor | |||||||
Tumor morphology | 100 | ✓ | |||||
Ductal | 29,473 | (80.39) | |||||
Lobular | 4109 | (11.20) | |||||
Mixed | 1464 | (3.99) | |||||
Other | 1612 | (4.40) | |||||
ply | |||||||
No. of positive lymph nodes | 1.53 | (3.53) | 97.6 | ✓ | |||
rec* | |||||||
Receptor status | 100 | ✓ | |||||
Triple+ | 1983 | (5.40) | |||||
HR+ | 28,170 | (76.84) | |||||
HR− | 2048 | (5.58) | |||||
Triple− | 4457 | (12.16) | |||||
